BEN stock · GRCE stock

BEN vs GRCE · P/E 36, rev $8.77B vs $35.0M cap

Franklin Resources Inc (BEN) versus Grace Therapeutics, Inc. (GRCE) — a side-by-side from cached financials, not a winner call.

Franklin Resources Inc (BEN) is a asset management company listed on US.

Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.

Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.

GRCE does not have a complete income-statement cache yet.

BEN currently screens at market cap $13.09B and trailing P/E 35.6. GRCE currently screens at market cap $35.0M.

Not investment advice. Open the BEN and GRCE stock pages for the full models.

Not investment advice.

Popular Stock Comparisons